NHAS
Novo Holdings A/S Portfolio holdings
AUM
$1.42B
This Quarter Return
+14.63%
1 Year Return
+12.08%
3 Year Return
+99.82%
5 Year Return
+98.46%
10 Year Return
+612.59%
AUM
$1.39B
AUM Growth
+$1.39B
(+18%)
Cap. Flow
-$15.8M
Cap. Flow
% of AUM
-1.14%
Top 10 Holdings %
Top 10 Hldgs %
92.12%
Holding
21
New
6
Increased
1
Reduced
5
Closed
1
Top Buys
| 1 |
TBRA
Tobira Therapeutics, Inc. Common Stock
TBRA
|
$46.5M |
| 2 |
ADAP
Adaptimmune Therapeutics
ADAP
|
$32.3M |
| 3 |
CLCD
CoLucid Pharmaceuticals, Inc.
CLCD
|
$27.2M |
| 4 |
HTGM
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
|
$14.3M |
| 5 |
Glaukos
GKOS
|
$2.17M |
Top Sells
| 1 |
ALDR
Alder Biopharmaceuticals, Inc.
ALDR
|
$66.2M |
| 2 |
NVRO
NEVRO CORP.
NVRO
|
$36M |
| 3 |
OTIC
Otonomy, Inc.
OTIC
|
$29.9M |
| 4 |
TTPH
Tetraphase Pharmaceuticals, Inc.
TTPH
|
$8.48M |
| 5 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$5.64M |
Sector Composition
| 1 | Healthcare | 59.12% |
